Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

ETOMIDATE FOR INDUCTION OF ANESTHESIA AT CESAREAN-SECTION - COMPARISON WITH THIOPENTONE BRITISH JOURNAL OF ANAESTHESIA Downing, J. W., BULEY, R. J., BROCKUTNE, J. G., HOULTON, P. C. 1979; 51 (2): 135-140

Abstract

Thirty mothers undergoing elective Caesarean section received thiopentone 3.5 mg kg-1 and 30 received etomidate 0.3 mg kg-1 for induction of anaesthesia. Subsequent management of anaesthesia was identical in both groups. Maternal to fetal base excess differences and the degree of biochemical correlation between mother and infant were more favourable following etomidate than following thiopentone. The clinical status of the newborn was considered superior with etomidate.

View details for Web of Science ID A1979GJ93800010

View details for PubMedID 426990